Optos gets 510(k) for microperimetry

Article

Optos plc has received 510(k) clearance from the FDA for microperimetry as part of the OptosOCT SLO.

 

Marlborough, MA-Optos plc has received 510(k) clearance from the FDA for microperimetry as part of the OptosOCT SLO. The device combines spectral optical coherence tomographic (OCT) imaging with a scanning laser ophthalmoscope (SLO).

Microperimetry assesses retinal sensitivity and provides a precise correlation between structural pathology and corresponding visual functional defects. The OptosOCT SLO is the only device on the market that can conduct structural OCT and functional microperimetry testing, according to the company.

“We continue to strive to provide innovative technology to the market,” said Roy Davis, chief executive officer of Optos. “With this 510(k) clearance for microperimetry, we once again offer a unique tool that allows eye-care professionals to see more, diagnose more, and treat more diseases earlier.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
TENAYA, LUCERNE year 2 data reveals promising results for faricimab
How to diagnose geographic atrophy earlier
World Sight Day 2022: Eye care professionals share what global vision means to them
Samsara Vision update: Concerto trial recruiting patients with late-stage AMD
Understanding fluid dynamics in wet macular degeneration
YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME
What are you most excited about in the field of retina? Tunde Peto, MD, PhD weighs in
Leveraging noninvasive ophthalmic imaging for patients with Alzheimer disease and analyzing UK Biobank data
EURETINA 2022: Leadership discusses what to expect, outlines Women in Retina program
DAVIO trial update: 12-month safety results indicate no serious adverse events, reduced treatment burden
© 2024 MJH Life Sciences

All rights reserved.